A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children

NCT00159874 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Sildenafil citrate
DRUG: Sildenafil citrate
DRUG: Sildenafil citrate

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.